A Meta-Analysis of Structural and Functional Brain Imaging in Dementia of the Alzheimer's Type: A Neuroimaging Profile

被引:0
作者
Konstantine K. Zakzanis
Simon J. Graham
Zachariah Campbell
机构
[1] University of Toronto,Division of Life Sciences
[2] Imaging/Bioengineering Research,Department of Medical Biophysics, Faculty of Medicine
[3] Sunnybrook & Women's College Health Science Centre,undefined
[4] Rotman Research Institute,undefined
[5] Baycrest Centre for Geriatric Care,undefined
[6] University of Toronto,undefined
来源
Neuropsychology Review | 2003年 / 13卷
关键词
Alzheimer's disease; neuroimaging; MRI; CT; SPECT; PET; review;
D O I
暂无
中图分类号
学科分类号
摘要
We conducted a quantitative review of the imaging literature using meta-analytic methodology to characterize further the magnitude of hippocampal deficit in probable Alzheimer's disease (AD) and to determine whether other neuroanatomic structures in AD can better discriminate the disease from normal aging. Additionally, we parceled the discriminability of neuroanatomic structures by duration of disease to determine those structures most sensitive to AD in its early and late stages. One hundred twenty-one studies published between 1984 and 2000 met criteria for inclusion in the present analysis. In total, structural (i.e., CT and MRI) and functional (i.e., SPECT and PET) neuroimaging results from 3511 patients with AD, and 1632 normal healthy controls were recorded across meta-analyses. Our results include neuroimaging profiles for both early onset and longer duration patients with AD. In sum, these profiles yield a signature of diagnostic markers in both cortical and subcortical neuroanatomic areas. This signature is consistent with the clinical phenomenology of Alzheimer's dementia and should aid in the positive identification of AD.
引用
收藏
页码:1 / 18
页数:17
相关论文
共 668 条
[1]  
Akiyama H.(1989)Crossed cerebellar and uncrossed basal ganglia and thalamic diaschisis in Alzheimer's disease Neurology 39 541-548
[2]  
Harrop R.(1993)Quantitative analysis of PET and MRI data in normal aging and Alzheimer's disease: Atrophy weighted total brain metabolism and absolute whole brain metabolism as reliable discriminators J. Nucl. Med. 34 1681-1687
[3]  
McGeer P. L.(1993)Early detection of Alzheimer's disease: Astatistical approach using positron emission tomographic data J. Cereb. Blood Flow Metab. 13 438-447
[4]  
Peppard R.(2001)In vivo mapping of gray matter loss with voxel based morphometry in mild Alzheimer's disease Neuroimage 14 298-309
[5]  
McGeer E. G.(1997)Quantitative MRI volume changes in late onset schizophrenia and Alzheimer's disease compared to normal controls Psychiatry Res. 68 65-75
[6]  
Alavi A.(1994)In vivo evaluation of brain iron in Alzheimer's disease and normal subjects using MRI Biol. Psychiatry 35 480-487
[7]  
Newberg A. B.(2000)Efficacy, adverse events, and treatment discontinuations in fluox-etine clinical studies of major depression: A meta-analysis of the 20-mg/day dose J. Clin. Psychiatry 61 722-728
[8]  
Souder E.(1989)Magnetic resonance imaging in Alzheimer's disease, multi-infarct dementia, alcoholic dementia and Korsakoff's psychosis Acta Psychiatr. Scand. 80 451-458
[9]  
Berlin J. A.(1994)Human corpus callosum in aging and Alzheimer's disease: A magnetic resonance imaging study Neurobiol. Aging 15 393-397
[10]  
Azari N. P.(1994)Metabolic effects of scopolamine and physostigmine in human brain measured by positron emission tomography J. Neu-rol. Sci. 123 44-51